Timing of JAK initiation, shingles vaccine administration can affect outcomes in rheumatoid arthritis

For patients with rheumatoid arthritis (RA), the timing of Janus kinase (JAK) inhibitor initiation relative to administration of recombinant zoster vaccine (RZV) can affect early response and arthritis control, according to a research letter published online July 21 in the Annals of Internal Medicine.

Source: Medical Xpress